NUP50
Nuclear pore complex protein Nup50 · Q9UKX7 · NUP50 on Sugi Atlas →
0 patent compounds predicted against NUP50, 0 high-confidence (nearest known ligand ≥ 0.5)
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to NUP50 by text similarity (a relevance ranking, not an exhaustive list)
Related proteins — ESM-2 sequence neighbours (a NUP50 binder may also engage these)
| Protein | Name | Similarity | |
|---|---|---|---|
| O08587 | — | 1.000 | O08587 → |
| Q9JIH2 | — | 1.000 | Q9JIH2 → |
| Q7K0D8 | — | 0.975 | Q7K0D8 → |
| Q5RB98 | — | 0.974 | Q5RB98 → |
| P42567 | — | 0.971 | P42567 → |
| P49790 | — | 0.971 | P49790 → |
| Q9C829 | — | 0.970 | Q9C829 → |
| Q80U93 | — | 0.970 | Q80U93 → |
| O15504 | — | 0.970 | O15504 → |
| O15117 | — | 0.969 | O15117 → |
| Q8CIC2 | — | 0.969 | Q8CIC2 → |
| EPS15 | Epidermal growth factor receptor substrate 15 | 0.968 | landscape → |
| P49793 | — | 0.968 | P49793 → |
| O60318 | — | 0.968 | O60318 → |
| Q5XGN1 | — | 0.968 | Q5XGN1 → |
| O60934 | — | 0.967 | O60934 → |
| P35658 | — | 0.967 | P35658 → |
| P32499 | — | 0.967 | P32499 → |
| Q4ADK7 | — | 0.967 | Q4ADK7 → |
| Q5ZI22 | — | 0.966 | Q5ZI22 → |
| Q5RCV3 | — | 0.966 | Q5RCV3 → |
| Q6PFD9 | — | 0.966 | Q6PFD9 → |
| Q8HXY9 | — | 0.966 | Q8HXY9 → |
| P49791 | — | 0.966 | P49791 → |
| Q28E45 | — | 0.966 | Q28E45 → |
| Q41583 | — | 0.966 | Q41583 → |
| Q3MHS2 | — | 0.965 | Q3MHS2 → |
| P98082 | — | 0.965 | P98082 → |
| Q8BMI3 | — | 0.965 | Q8BMI3 → |
| Q8VY07 | — | 0.965 | Q8VY07 → |